Pancreatic Cancer News

EMA recommends authorisation of Rasonque for metastatic pancreatic cancer - European Medicines Agency (EMA)

EMA recommends authorisation of Rasonque for metastatic pancreatic cancer European Medicines Agency (EMA)

Research Spotlight: Convening Our Community for Progress to Make Meaningful Change - Pancreatic Cancer Action Network

Research Spotlight: Convening Our Community for Progress to Make Meaningful Change Pancreatic Cancer Action Network

Revolution Medicines wins EU committee backing for pancreatic cancer treatment - Reuters

Revolution Medicines wins EU committee backing for pancreatic cancer treatment Reuters

Verastem’s KRAS inhibitor shows promise in pancreatic cancer - STAT

Verastem’s KRAS inhibitor shows promise in pancreatic cancer STAT

Verastem CEO claims RAS drug has 'set a new benchmark' for tricky cancer in early readout - Fierce Biotech

Verastem CEO claims RAS drug has 'set a new benchmark' for tricky cancer in early readout Fierce Biotech

Verastem makes its stand as a RevMed competitor in pancreatic cancer - Endpoints News

Verastem makes its stand as a RevMed competitor in pancreatic cancer Endpoints News

Lilly's obesity pill, RevMed's pancreatic cancer breakthrough among slew of CHMP endorsements in Europe - Fierce Pharma

Lilly's obesity pill, RevMed's pancreatic cancer breakthrough among slew of CHMP endorsements in Europe Fierce Pharma

Clonal heterogeneity in human pancreatic ductal adenocarcinoma and its impact on tumor progression - Nature

Clonal heterogeneity in human pancreatic ductal adenocarcinoma and its impact on tumor progression Nature

Swanton Fire & Rescue Lt. Sean Griewahn dies after battle with pancreatic cancer - WTVG

Swanton Fire & Rescue Lt. Sean Griewahn dies after battle with pancreatic cancer WTVG

Revolution Medicines Daraxonrasib: The Best Inventions of 2026 - Time Magazine

Revolution Medicines Daraxonrasib: The Best Inventions of 2026 Time Magazine

Pancreatic cancer cells continuously reshape DNA to evade treatment - News-Medical

Pancreatic cancer cells continuously reshape DNA to evade treatment News-Medical

Retired doctor and B.C. pancreatic cancer survivor speaks about early diagnosis — and self-advocacy - Vancouver Sun

Retired doctor and B.C. pancreatic cancer survivor speaks about early diagnosis — and self-advocacy Vancouver Sun

RevMed’s pancreatic cancer drug nears European approval - STAT

RevMed’s pancreatic cancer drug nears European approval STAT

Oncolytics Biotech Completes GOBLET Pancreatic Cancer Cohort Enrollment - The Clinical Trial Vanguard

Oncolytics Biotech Completes GOBLET Pancreatic Cancer Cohort Enrollment The Clinical Trial Vanguard

Scientists Reveal How Pancreatic Cancer Evolves to Evade Treatment - UC San Diego Today

Scientists Reveal How Pancreatic Cancer Evolves to Evade Treatment UC San Diego Today

RevMed’s pancreatic cancer drug inches closer to EU approval after panel’s backing - Pharmaceutical Technology

RevMed’s pancreatic cancer drug inches closer to EU approval after panel’s backing Pharmaceutical Technology

CHMP recommends first broad RAS-targeted therapy for metastatic pancreatic cancer - European Pharmaceutical Review

CHMP recommends first broad RAS-targeted therapy for metastatic pancreatic cancer European Pharmaceutical Review

RevMed nears EU okay for pancreatic cancer drug Rasonque - pharmaphorum

RevMed nears EU okay for pancreatic cancer drug Rasonque pharmaphorum

Daraxonrasib Receives Positive CHMP Opinion for Previously Treated Metastatic Pancreatic Cancer - Oncodaily

Daraxonrasib Receives Positive CHMP Opinion for Previously Treated Metastatic Pancreatic Cancer Oncodaily

CHMP Recommends Approval of Daraxonrasib for Previously Treated Metastatic Pancreatic Cancer - OncLive

CHMP Recommends Approval of Daraxonrasib for Previously Treated Metastatic Pancreatic Cancer OncLive

Propanc Biopharma’s Lead Asset PRP Reprograms Chemotherapy-Resistant Pancreatic Cancer Cells - GlobeNewswire

Propanc Biopharma’s Lead Asset PRP Reprograms Chemotherapy-Resistant Pancreatic Cancer Cells GlobeNewswire

Continuously evolving cells help pancreatic cancer evade treatment and spread - Medical Xpress

Continuously evolving cells help pancreatic cancer evade treatment and spread Medical Xpress

Verastem reports ‘robust’ response rate in pancreatic cancer subgroup where Rasonque struggled - BioSpace

Verastem reports ‘robust’ response rate in pancreatic cancer subgroup where Rasonque struggled BioSpace

5 Pancreatic Cancer Trials to Watch at ESMO 2026 - Oncodaily

5 Pancreatic Cancer Trials to Watch at ESMO 2026 Oncodaily

VS-7375 Elicits Responses in KRAS G12D–Mutated Pancreatic Cancer - OncLive

VS-7375 Elicits Responses in KRAS G12D–Mutated Pancreatic Cancer OncLive

OncLive Weekly News Quiz (10/16/2026): Did You Miss Crucial Bladder, Neuroendocrine, Pancreatic, and Liver Cancer Updates? - OncLive

OncLive Weekly News Quiz (10/16/2026): Did You Miss Crucial Bladder, Neuroendocrine, Pancreatic, and Liver Cancer Updates? OncLive

U of A cancer researcher dies of same disease she fought to cure - Arizona Daily Star

U of A cancer researcher dies of same disease she fought to cure Arizona Daily Star

Revolution’s Rasonque Gets Broad Pancreatic Cancer Recommendation in Europe - GenomeWeb

Revolution’s Rasonque Gets Broad Pancreatic Cancer Recommendation in Europe GenomeWeb

FDA approves new pill for pancreatic cancer treatment - FOX 8 Local First

FDA approves new pill for pancreatic cancer treatment FOX 8 Local First

EMA committee backs Revolution Medicines' Rasonque for metastatic pancreatic cancer - Dealroom

EMA committee backs Revolution Medicines' Rasonque for metastatic pancreatic cancer Dealroom

Analysts eye RevMed’s pancreatic cancer launch, Merck’s data blitz for Q3 earnings - BioSpace

Analysts eye RevMed’s pancreatic cancer launch, Merck’s data blitz for Q3 earnings BioSpace

Europe gives the green light to the daily pill that increases life expectancy for pancreatic cancer patients - El Mundo America

Europe gives the green light to the daily pill that increases life expectancy for pancreatic cancer patients El Mundo America